Clive Ballard researcher
Ballard, C. G.
Ballard, Clive
Ballard, Clive G. (1964- ).
Ballard, Clive G.
Ballard, Clive 1964-
VIAF ID: 270622784 (Personal)
Permalink: http://viaf.org/viaf/270622784
Preferred Forms
- 100 1 _ ‡a Ballard, C. G.
-
-
- 100 1 _ ‡a Ballard, Clive
-
- 100 1 _ ‡a Ballard, Clive G.
-
-
- 100 1 _ ‡a Ballard, Clive ‡d 1964-
- 100 0 _ ‡a Clive Ballard ‡c researcher
4xx's: Alternate Name Forms (6)
5xx's: Related Names (5)
- 510 2 _ ‡a King's College London ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a London ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a University of Birmingham ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a University of Exeter ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a University of Leicester ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Dementia, 2001: | |
Dementia : management of behavioural and psychological symptoms | |
Management of behavioral problems in Alzheimer's disease | |
Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy | |
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. | |
Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease. | |
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design | |
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. | |
META-ANALYSIS OF AARC AND EMOTIONAL AND PHYSICAL WELL-BEING | |
Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults | |
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial | |
Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease | |
MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. | |
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science | |
Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. | |
Neurochemistry of severe dementia | |
Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology | |
Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. | |
Neuroleptic drugs in dementia: benefits and harm | |
Neuroleptic sensitivity to risperidone in Lewy body dementia. | |
Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. | |
Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. | |
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. | |
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease | |
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future | |
Neuropsychiatric symptoms in dementia: importance and treatment considerations. | |
Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. | |
Neuropsychological deficits in older stroke patients. | |
New guidelines on disorders associated with dementia | |
New Therapeutic Strategies for Lewy Body Dementias | |
NHS Continuing Care | |
Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. | |
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia | |
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies | |
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias | |
Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies | |
Non-pharmacological interventions in dementia | |
NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors. | |
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. | |
Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England | |
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. | |
Online assessment of risk factors for dementia and cognitive function in healthy adults. | |
An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults | |
Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease | |
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial | |
Overlap between pathology of Alzheimer disease and vascular dementia | |
Pain treatment of agitation in patients with dementia: a systematic review | |
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity | |
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation | |
Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment | |
Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry | |
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial. | |
Person-centred care and care mapping in dementia | |
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels | |
Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs. | |
Pimavanserin: Potential Treatment For Dementia-Related Psychosis | |
Psychosis in parkinson's disease | |
A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. | |
A role for APP in Wnt signalling links synapse loss with β-amyloid production | |
Rozpoznawanie i leczenie otępienia z ciałami Lewy'ego : czwarte stanowisko DLB Consortium = Diagnosis and management of dementia with Lewy bodies : fourth consensus report of the DLB Consortium | |
Rozpoznawanie i leczenie otępienia z ciałami Lewy'ego / Ian G. McKeith [i inni] // MP Medycna Praktyczna. Neurologia. - 5 (47) 2017, strony 21-39. | |
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders |